ExecutiveOrdersEO
EO 14221Executive OrderTrump 47 · R

Executive Order 14221

Making America Healthy Again by Empowering Patients With Clear, Accurate, and Actionable Healthcare Pricing Information

This executive order directs the Secretaries of Treasury, Labor, and HHS to strengthen enforcement of healthcare price transparency rules originally issued under EO 13877 (2019). Within 90 days, they must require actual (not estimated) price disclosure, standardize pricing information for comparability, and update enforcement policies to ensure hospitals and health plans comply with transparency requirements.

Federal Register Open PDF 90 FR 11005

Impact dates

  1. Require actual price disclosure; standardize pricing; update enforcement policies

Market exposure

Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

Sectors

PharmaTechnology & softwareOther industrial

Mechanisms

LicensingProcurement

Role pressure

  • AdverseDownstream manufacturer — Hospitals and health plans face stricter compliance burdens and potential enforcement penalties for non-disclosure
  • UncertainImporter — Pharmacy benefit managers and insurers may face pressure to disclose actual drug prices paid, potentially revealing opaque rebate structures
  • MixedDomestic producer — Increased price transparency could increase competition and pressure margins for some providers, while reducing costs for employers/patients

Geographies

US

Illustrative public companies

Curated watchlist matches by sector/role — incomplete; not a recommendation.

MMM3MGOOGLAlphabetAAPLAppleCATCaterpillarLLYEli LillyFCXFreeport-McMoRanGEVGE VernovaHONHoneywellQQQInvesco QQQ TrustJNJJohnson & JohnsonMRKMerckMETAMeta PlatformsMSFTMicrosoftNVSNovartisNVDANVIDIAORCLOraclePFEPfizerSPYSPDR S&P 500 ETF

Confidence: medium · Policy alerts

Key directives

  • Secretaries of Treasury, Labor, and HHS shall rapidly implement and enforce healthcare price transparency regulations from EO 13877
  • Within 90 days: require disclosure of actual prices, not estimates
  • Within 90 days: issue updated guidance or proposed regulatory action for standardized, easily comparable pricing information
  • Within 90 days: issue guidance or proposed regulatory action updating enforcement policies for compliance

Who is ordered

Timeline

Immediate

  • EO issuance and directive to three Cabinet secretaries

Near term (90d)

  • Require actual price disclosure (not estimates)
  • Issue updated guidance/regulation for standardized comparable pricing
  • Issue updated enforcement policies for compliance

Long term

  • Potential expansion of price transparency requirements
  • Healthcare cost reductions if fully implemented
  • Increased market competition in healthcare services

Risks & tensions

  • Enforcement depends on agency resources and 'availability of appropriations' (Sec. 4(b))
  • Prior administration's perceived non-enforcement suggests implementation gaps may be structural, not merely policy-driven
  • Vague on penalties or specific enforcement mechanisms—'all necessary and appropriate action' leaves discretion to agencies
  • Proposed regulatory action language suggests rulemaking delays possible before binding requirements
Executive Order 14221: Making America Healthy Again by Empowering Patients With Clear, Accurate, and Actionable Healthcare Pricing Information · Executive Orders